News

CPI-300, a novel antidepressant, with a high strength of bupropion hydrochloride (HCl), is the active ingredient in Wellbutrin XL. Pillar5 has responded to all queries from the FDA

Zoely, a monophasic combination of 2 steroid hormones – 17-beta estradiol and nomegestrol acetate, will be made available in a convenient 24 day active and 4 day placebo

The integrated content along with T SystemEV aids providers with extensive drug and clinical data to improve the accuracy and safety of patient care for adult and pediatric

Olmesartan medoxomil, a member of the angiotensin receptor blocker (ARB) class of antihypertensive medications, is indicated for the treatment of hypertension. The companies’ Mexican subsidiaries Daiichi Sankyo Mexico

Earlier, Perforomist (formoterol fumarate) Inhalation Solution 20mcg/2ml vial was under revaluation by Sepracor, now known as Sunovion Pharmaceuticals. According to Dey Pharma, the two intended reissued patents and

The increase in revenue is driven by higher prescription volume and price inflation on brand drugs, offset by the impact of the increase in generic utilization. Catalyst‘s net

The FDA reserves final approval of the product, however, until all exclusivity or patent challenges have been resolved, specifically the current patent litigation brought against Intelliject by King

The double-blind, randomized and controlled trial is expected to compare two dose levels of CF101 to placebo. The company anticipates to recruit around 300 patients at 17 centers.

Net income was $2.61bn, compared to $2.48bn for the same period in the prior year. For the six months ended 2011 revenues were $33.49bn, compared to $33.71bn for